Key result
Serum adenosine deaminase levels were significantly higher in obese patients with diabetes (22.71 IU/L) and obese patients without diabetes (21.79 IU/L) compared to healthy controls (17.40 IU/L).
Why the study?
Because adenosine deaminase is putatively associated with inflammation and adipose tissue inflammation marks insulin resistance in obese T2DM patients, the study evaluated serum ADA in T2DM.
Cross-Sectional (n=300)
No
Absolute Event Rate: 22.71% vs 17.4%
p-value: p=<0.005
Serum ADA levels are elevated in obesity and further increased in the presence of type 2 diabetes, suggesting a potential role as a biomarker for insulin resistance and metabolic derangement.
Background: Obesity is a complex disorder that involves some degree of over-consumption1 coupled with a metabolic derangement. As ADA has been putatively associated with inflammation, and adipose tissue inflammation is the hallmark of insulin resistance in obese T2DM patients. This study attempted to compare serum ADA in T2DM subjects.Methods: This observational cross-sectional study was conducted in the Department of Biochemistry at MGM Medical College and MY Hospital. All the patients and controls were clinically examined, and routine biochemical tests were analyzed for all subjects. ANOVA has been applied to assess the variance between groups.Results: Mean age of controls was 56.91 years where as mean age in the group of a subject with Obesity with diabetes was 40.91 years and with Obesity without diabetes was 48.10 years. ADA level was more among diabetes patients having obesity than diabetes patients having no obesity and controls.Conclusions: This is very much evident through this study that ADA may be treated as prognostic predictor of diabetes either linked to obesity or not, though more studies are warranted in same direction to make this finding conclusive and acceptable biochemical evidence.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2019) conducted a cross-sectional in Type 2 Diabetes Mellitus and Obesity (n=300). Obesity and Type 2 Diabetes vs. Healthy controls was evaluated on Serum adenosine deaminase (ADA) level (IU/L) (p=<0.005). Serum adenosine deaminase levels were significantly higher in obese patients with diabetes (22.71 IU/L) and obese patients without diabetes (21.79 IU/L) compared to healthy controls (17.40 IU/L).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: